SCHEMBL3438894

SCHEMBL3438894

CN(CC(C)(C)C)S(=O)(=O)N=[N+]=[N-]

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3438896 0.76 ESR2 (0.38)
SCHEMBL6543221 0.71
SCHEMBL3438902 0.67 GSTO1 (0.32)
SCHEMBL1697335 0.66 MEN1 (0.41)
SCHEMBL22517371 0.66 ALDH1A1 (0.44)
SCHEMBL15617694 0.64 CA12 (0.33)
SCHEMBL21789200 0.64
SCHEMBL17854051 0.64
SCHEMBL11578655 0.64 MEN1 (0.30)
SCHEMBL13147989 0.63

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114539106-B Synthetic method of stable isotope labeled taurinamide hydrochloride 梯尔希(南京)药物研发有限公司 2023-05-02 CN disclosed
US-20220186222-A1 LINKAGE MODIFIED OLIGOMERIC COMPOUNDS AND USES THEREOF IONIS PHARMACEUTICALS, INC. (US) 2022-06-16 US disclosed
US-11155527-B2 Macromolecules comprising triazoles and related compounds MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2021-10-26 US disclosed
WO-2021030778-A1 LINKAGE MODIFIED OLIGOMERIC COMPOUNDS AND USES THEREOF IONIS PHARMACEUTICALS, INC. (US) 2021-02-18 WO disclosed
US-20120101271-A1 DIAMINE SYNTHESIS VIA CATALYTIC C-H AMINATION OF AZIDES NATIONAL SCIENCE FOUNDATION 2012-04-26 US disclosed
US-20120101271-A1 DIAMINE SYNTHESIS VIA CATALYTIC C-H AMINATION OF AZIDES NATIONAL SCIENCE FOUNDATION 2012-04-26 US disclosed
EP-1756089-B1 MERCAPTOIMIDAZOLES AS CCR2 RECEPTOR ANTAGONISTS JANSSEN PHARMACEUTICA NV (BE) 2008-10-22 EP disclosed